President Donald Trump’s nominee for FDA Commissioner, Martin A. Makary, MD, sought to assure senators that if confirmed, he would support efforts to expedite reviews of new drugs indicted for rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback